血管造影市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

心血管疾病，包括心脏病发作和中风等心血管疾病，是过早死亡的第一大原因。

根据世界卫生组织 (WHO) 的数据，2017 年心血管疾病每年导致约 1790 万人死亡，预计到 2030 年这一数字将增加到 2360 万以上。 因此，心血管疾病的增加可能会推动对血管造影设备的需求，并最终导致血管造影设备市场的增长。 此外，技术的快速进步、公众意识的提高以及对微创手术的高度偏好等其他因素也补充了市场增长。

血管造影设备市场趋势

预计在预测期内，医院部分将主导市场

医院部门占据主导地位的主要驱动因素是更高的患者容量、更好的资源可用性、多样化的地理覆盖范围、配套医疗基础设施和程序的可用性、熟练劳动力的可用性、政府资金的可负担性。 在发达市场和新兴市场，随着心血管疾病死亡人数的增加，复杂心脏病病例的数量也在增加。 与专科诊所相比，医院因其更好的可及性和可负担性而吸引了更多的心血管疾病患者。 由于受益于大宗采购折扣以及与製造商和供应商的贸易协议，该医院的利润指数也在改善。 此外，这些贸易协定将为製造商及早获得及时升级和技术先进的产品开闢新途径，从而提高医院的治疗能力。

北美主导着血管造影设备市场

由于微创手术的高采用率、报销制度的加强、老年人口的增长以及医疗设备的高更换率，北美在血管造影市场占据主导地位。 强大的医疗器械公司网络、遍布城市和州的大量医院以及获得融资机会是该地区市场主导地位的主要驱动力。 此外，政府机构的大力支持促进了该地区医疗保健部门心血管疾病整体治疗所需的发展。

欧洲是仅次于北美的第二大市场。 欧洲国家的很大份额归因于心血管疾病患病率高、政府投资高、产品批准过程加快以及许多血管造影筛查程序到位而导致血管造影设备的采用率上升。

血管造影设备市场竞争分析

血管造影市场正在整合且竞争激烈。 一些全球参与者主导着市场，这主要是由于严格的产品审批流程和对重要技术能力的需求。 主要市场参与者包括 AngioDynamics Inc.、波士顿科学公司、佳能医疗系统公司、Cardinal Health Inc.、GE Healthcare、Medtronic PLC、Koninklijke Philips NV、Shimadzu Corporation、Siemens Healthineers AG 和 Terumo Corporation。

其他好处

• Excel 格式的市场预测 (ME) 表
• 3 个月的分析师支持

内容

第一章介绍

• 调查结果
• 调查假设
• 本次调查的范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

• 市场概览
• 市场驱动因素
  • 老龄化人口的增加和心血管疾病患病率的增加
  • 微创手术对介入血管造影的需求不断扩大
• 市场製约因素
  • 治疗和设备成本高
  • 与血管造影程序相关的风险
• 波特的五力分析
  • 新进入者的威胁
  • 买方/消费者议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争公司之间的敌对关係

第 5 章市场细分

• 按产品分类
  • 血管造影设备
  • 消耗品
    • 导管
    • 导丝
    • 造影剂
    • 切口闭合装置
    • 配饰
• 按技术
  • 核磁共振
  • CT
  • X光
  • 其他技术
• 通过使用
  • 大脑
  • 颈动脉
  • 外周血管
  • 主动脉
  • 冠状动脉
  • 其他用途
• 最终用户
  • 医院
  • 诊断中心
  • 门诊手术中心
• 按地区
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 中东和非洲
    • 海湾合作委员会
    • 南非
    • 其他中东和非洲地区
  • 南美洲地区
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章竞争格局

• 公司简介
  • AngioDynamics Inc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Cardinal Health Inc.
  • GE Healthcare
  • Medtronic PLC
  • Koninklijke Philips NV
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Terumo Corporation

第7章 市场机会今后动向

The cardiovascular diseases which include heart attacks, strokes, and other circulatory diseases have become the leading cause of premature deaths. According to the World Health Organization, 2017, cardiovascular diseases account for nearly 17.9 million deaths per year, and this number is expected to grow to more than 23.6 million by 2030. Hence, the increasing number of cardiovascular diseases is driving the demand for angiography devices, which may ultimately result in the growth of the angiography devices market. Furthermore, other factors, such as rapid technological advances, increasing awareness of the population, and a high preference for minimally invasive procedures, are supplementing the market growth.

Angiography Devices Market Trends

The Hospital Segment is Expected to Dominate the Market During the Forecast Period

The main factors attributing to the dominance of the hospital segment are the availability of the larger patient pool, high resource availability, high penetration in diverse geographical locations, availability of accompanying healthcare infrastructure and procedures, availability of skilled labor, and affordability via government funding. A large number of complex cardiac disease cases are on the rise, with the growth in the number of deaths due to cardiovascular diseases, across both the developed and emerging markets. The high accessibility and affordability of hospitals, as compared to the specialty clinics, attract a large patient population suffering from cardiovascular diseases. The profitability index of hospitals also increases, as they benefit from the bulk purchase discounts and trade agreements with the manufacturers and suppliers. Furthermore, these trade agreements open new avenues to timely upgradation and early access to technologically advanced products by the manufacturers, enhancing the hospital's treatment capability.

North America Dominates the Angiography Devices Market

North America dominates the angiography devices market, owing to the high adoption rate of minimally invasive procedures, availability of reimbursements, rising geriatric population, and high replacement rates of medical equipment. Factors, such as a good network of medical device companies and a large number of hospitals across cities and states with good funding opportunities, primarily help the region dominate the market. Furthermore, good support from government facilities helps in the development required for the overall treatment of cardiovascular diseases in the healthcare sector of the region.

Europe is the second-largest market after North America. The significant share of the European countries can be attributed to the high prevalence of cardiovascular diseases, high government investments, faster product approval procedures, and rising adoption of angiography devices due to a large number of angiography screening procedures being performed.

Angiography Devices Market Competitive Analysis

The angiography devices market is consolidated and highly competitive. A few global players dominate the market, primarily due to the stringent product approval process, along with the need for significant technological capabilities. The key market players include AngioDynamics Inc., Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., GE Healthcare, Medtronic PLC, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, and Terumo Corporation.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Geriatric Population and Increasing Prevalence of Cardiovascular Diseases
  • 4.2.2 Growing Demand for Interventional Angiography in Minimally Invasive Surgeries
• 4.3 Market Restraints
  • 4.3.1 High Procedure and Equipment Cost
  • 4.3.2 Risks Associated with Angiography Procedures
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Product
  • 5.1.1 Angiographic Systems
  • 5.1.2 Consumables
    • 5.1.2.1 Catheters
    • 5.1.2.2 Guidewires
    • 5.1.2.3 Contrast Media
    • 5.1.2.4 Incision Closure Devices
    • 5.1.2.5 Accessories
• 5.2 By Technology
  • 5.2.1 MRI
  • 5.2.2 CT
  • 5.2.3 X-ray
  • 5.2.4 Other Technologies
• 5.3 By Application
  • 5.3.1 Cerebral
  • 5.3.2 Carotid
  • 5.3.3 Peripheral
  • 5.3.4 Aortic
  • 5.3.5 Coronary
  • 5.3.6 Other Applications
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Diagnostic Centers
  • 5.4.3 Ambulatory Surgical Centers
• 5.5 Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle-East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle-East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 AngioDynamics Inc.
  • 6.1.2 Boston Scientific Corporation
  • 6.1.3 Abbott Laboratories
  • 6.1.4 Cardinal Health Inc.
  • 6.1.5 GE Healthcare
  • 6.1.6 Medtronic PLC
  • 6.1.7 Koninklijke Philips NV
  • 6.1.8 Shimadzu Corporation
  • 6.1.9 Siemens Healthineers AG
  • 6.1.10 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS